Omega Healthcare Investors OHI
Omega Healthcare Investors Q2 FY25: revenue $282.5M, up 12%; diluted EPS $0.46
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000888491-25-000025
Key figures from this report
These are the numbers Omega Healthcare Investors reported for Q2 FY25, the quarter ended Jun 30, 2025, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$282.5M+12% from $252.7M in Q2 FY2410-Q income statement, on EDGAR
- Net income$136.6M+20% from $113.9M in Q2 FY2410-Q income statement, on EDGAR
- Diluted EPS$0.46+2% from $0.45 in Q2 FY2410-Q income statement, on EDGAR
- Cash and cash equivalents$734.2M+1986% from $35.2M in Q2 FY2410-Q balance sheet, on EDGAR
- Cash from operations$239.3M+30% from $184.1M in Q2 FY2410-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 6798 and related industry codes: the same peer list as the financial tables.
- BXP BXP public float $10.7B, Jun 30, 2025
- Host Hotels & Resorts HST public float $10.4B, Jun 30, 2025
- Lamar Advertising LAMR public float $10.2B, Jun 30, 2025
- Pacific Oak Strategic Opportunity REIT PCOK
- American Homes 4 Rent AMH public float $11.7B, Jun 30, 2025
